Extending immunosuppressive drug coverage for the lifetime of kidney patients, instead of only covering dialysis, would be a cost-effective way for the federal government to reduce the costs of posttransplant care while improving clinical outcomes for patients.
It is difficult to argue that consumers are maximizing their welfare by consuming trans fats, particularly because the production and taste costs of replacing them do not outweigh the health benefits.
The media has a responsibility to do more to counter the stigma that has been placed on HIV and AIDS so that more at-risk patients will seek treatment.
Joseph Turow, PhD, Robert Gellman, JD, and Judith Turow, MD
Health marketers use a number of means to collect information about consumers, which when combined with health record information, could constitute a violation of patient privacy.